Skip to main content
SpringerLink
Account
Fig. 1 | Nanoscale Research Letters

Fig. 1

From: hGC33-Modified and Sorafenib-Loaded Nanoparticles have a Synergistic Anti-Hepatoma Effect by Inhibiting Wnt Signaling Pathway

Fig. 1

Characterization of NPs. a TEM characterization of NPs, the scale bar indicates 100 nM; b the 1H NMR spectra of synthetic hGC33-PLGA-b-PEG in CDCl3; c FTIR spectra of hGC33-PEG-b-PLGA and PEG-b- PLGA; d cumulative release profiles of SFB-NP and hGC33-SFB-NP in PBS (pH = 7.4) at 37 °C; e size changes of NPs incubated in DMEM medium containing 10% FBS over 14 d; f size changes of NPs incubated in PBS over 14 d. SFB, sorafenib; TEM, transmission electron microscopy; NPs, nanoparticles; 1H NMR, 1H-nuclear magnetic resonance spectroscopy; FTIR, Fourier transform infrared spectroscopy

Back to article page

Search

Navigation